Blood Tests for Personalized Breast and Ovarian Cancer Risk
Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer
['FUNDING_U01'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-11161426
This project aims to develop new blood tests to better understand a woman's personal risk for breast and ovarian cancer.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11161426 on ClinicalTrials.gov |
What this research studies
We are working to create new blood tests that look for specific proteins and natural defenses (autoantibodies) in your blood. These tests could help us understand your individual risk of having breast or ovarian cancer. The goal is to combine these blood test results with your personal health information to provide a more accurate picture of your cancer risk. This personalized information could then help guide decisions about when and how often you should be screened for these cancers, potentially leading to earlier detection.
Who could benefit from this research
Good fit: Women who are interested in understanding their personal risk for breast and ovarian cancer and who may be considering different screening options could be ideal candidates for future applications of this research.
Not a fit: Patients already diagnosed with breast or ovarian cancer may not directly benefit from this specific risk assessment tool, as it focuses on early detection before diagnosis.
Why it matters
Potential benefit: If successful, this work could lead to more personalized and effective screening strategies for breast and ovarian cancers, helping to detect them earlier.
How similar studies have performed: Previous work by the research team has identified promising proteins and autoantibodies that are being further tested in this project.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FAHRMANN, JOHANNES F — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: FAHRMANN, JOHANNES F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Breast Cancer, Breast Cancer Detection, Breast Cancer Gail Model, Breast Cancer Gail Model Risk Assessment Tool, Breast Cancer Prevention